Form 424B5 MICROSTRATEGY Inc

Go back to Form 424B5 MICROSTRATEGY Inc

Strategy (MSTR) Files Prospectus Supplement for $2.1B of Preferred Stock

May 22, 2025 7:55 AM EDT

Strategy (NASDAQ: MSTR) disclosed:

We have entered into a Sales Agreement (the Sales Agreement) with TD Securities (USA) LLC, Barclays Capital Inc., and The Benchmark Company, LLC (collectively, the Agents), dated May 22, 2025, relating to the sale of shares of our 10.00% Series A Perpetual Strife Preferred Stock, which we refer to as our perpetual strife preferred stock, offered by this prospectus supplement. In accordance with the terms of the Sales Agreement, under this prospectus supplement, we may offer and sell shares of our perpetual strife preferred stock having an aggregate offering price of up to $2,100,000,000... More